在韩国等待乳腺癌治疗的时间:一项全国性队列研究
Young-Jin Lee1, Jae Ho Jeong2, Jinhong Jung3
1Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Journal of breast cancer
|August 11, 2023
概括
在韩国,乳腺癌治疗的等待时间增加了,尤其是前往首尔的患者. 诸如先前病史和三级医院治疗等因素也会导致延误.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 及时治疗乳腺癌对于患者的治疗结果至关重要.
- 了解治疗延迟对于改善医疗保健获取和效率至关重要.
研究的目的:
- 分析韩国初始乳腺癌治疗等待时间的趋势.
- 确定导致治疗延迟的因素,特别是超过诊断后30天的因素.
主要方法:
- 全国范围的回顾性队列研究,使用健康保险审查和评估数据.
- 基于患者的活检和治疗区域,诊断年和治疗类型等待时间的分析.
- 多变量逻辑回归用于识别延迟治疗的预测因素 (定义为诊断后>30天).
主要成果:
- 2010年至2017年间,初始乳腺癌治疗的平均等待时间从8天增加到14天.
- 与当地接受治疗 (地铁-地铁,其他-其他) 患者相比,前往首尔 (地铁-首尔,其他-首尔) 的患者的等待时间明显更长.
- 手术延迟 (>30天) 与前往首尔,之前的病史和在第三级医院接受治疗有很强的关联.
结论:
- 在韩国,乳腺癌治疗的等待时间在全国范围内有所延长.
- 存在地理差异,在首尔寻求治疗的患者面临最长的延迟.
- 患者病史和医院类型等因素影响治疗的及时性,突出了医疗保健系统改进的领域.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.7K
相关概念视频
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
115
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
115
01:21Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384